Suppr超能文献

2022年印度和德国的抗菌药物耐药负担:基于“同一健康”视角的系统分析

Antimicrobial resistance burden in India and Germany in 2022: A systematic analysis along with One Health perspective.

作者信息

Pandey Ramendra Pati, Kaur Kirtanjot, Ahmad Saheem, Mukherjee Riya, Chang Chung-Ming

机构信息

Graduate Institute of Biomedical Sciences, Chang Gung University, No. 259, Wenhua 1st Road, Guishan District, Taoyuan City, 33302, Taiwan.

Biotechnology Industry, Chang Gung University, No. 259, Wenhua 1st Road, Guishan District, Taoyuan City, 33302, Taiwan.

出版信息

Heliyon. 2024 Sep 14;10(18):e37910. doi: 10.1016/j.heliyon.2024.e37910. eCollection 2024 Sep 30.

Abstract

Globally increasing antibiotic resistance has been linked to the extensive use of antibiotics in medical, veterinary, and agricultural Practices. This study aims to investigate the correlations of antimicrobial-resistant of various pathogens in three compartments: humans, animals and the environment in India and Germany. A systematic search was carried out in Medline via PubMed, Google Scholar, and science direct, including studies published in 2022. Out of 532 papers, 24 were considered for meta-analysis. Our findings reveals that in India, β-lactam is highly resistant in animals. Quinolone, on the other hand, was highly resistant in humans. In the environmental sectors, aminoglycosides and β-lactams is resistant. While in Germany, β-lactam resistance is high across all three sectors. However, was the most frequent and resistant pathogen in both countries, with significant resistance to β-lactams and cephalosporins across all compartments. These results underscore the critical need for monitoring antibiotic resistance patterns and developing targeted antibiotic regimens. A One Health-based intervention strategy is essential to mitigate the spread of AMR and improve health outcomes globally.

摘要

全球范围内抗生素耐药性的增加与医学、兽医和农业实践中抗生素的广泛使用有关。本研究旨在调查印度和德国人类、动物和环境这三个领域中各种病原体的抗菌耐药性之间的相关性。通过PubMed、谷歌学术和科学直投在Medline上进行了系统检索,包括2022年发表的研究。在532篇论文中,有24篇被纳入荟萃分析。我们的研究结果表明,在印度,动物对β-内酰胺类药物高度耐药。另一方面,喹诺酮类药物在人类中耐药性很高。在环境领域,氨基糖苷类药物和β-内酰胺类药物具有耐药性。而在德国,所有三个领域对β-内酰胺类药物的耐药性都很高。然而,在这两个国家都是最常见且具有耐药性的病原体,在所有领域对β-内酰胺类药物和头孢菌素类药物都有显著耐药性。这些结果强调了监测抗生素耐药模式和制定针对性抗生素治疗方案的迫切需求。基于“同一健康”的干预策略对于减轻抗菌药物耐药性的传播和改善全球健康结果至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a06/11425110/148cbced183b/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验